Watch Ticker

CERo Therapeutics Holdings, Inc. Common Stock

Go to CERo Therapeutics Holdings, Inc. Common Stock Website

$7.80

0.16 (2.09%)

Live

Previous Close

$7.64

Day Range

$7.3 - $7.92

Previous Day Range

$7.2525 - $7.7351

Market Cap

$9.2 million USD

Day Vol.

44083

Previous Day Vol.

22455

Currency

USD

Primary Exchange

None

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integra...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO

CERo Therapeutics Holdings, Inc. (CERO) has appointed Chris Ehrlich as its new CEO. The company is advancing the development of next-generation engineered T cell therapeutics for cancer treatment, with plans to initiate clinical trials for its lead product candidate CER-1236 in early 2025 for acute myeloid leukemia (AML).

Related tickers: CERO, CEROW.

Read Full Article

CERo Therapeutics Holdings, Inc. - CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236

Company anticipates near term filing of Investigational New Drug Application to FDA

Related tickers: CERO.

Read Full Article

Trending Tickers

Please sign in to view